诊断与治疗技术评估。免疫增强疗法。

JAMA. 1988 Jun 17;259(23):3477-8.

The scientific evidence to date, as well as the history of IAT, will allow no other conclusion than that IAT is unequivocally dangerous to its patients and of no proved value as a treatment for cancer. Physicians who know of patients receiving IAT must be aware of the high risk those people are incurring for life-threatening infections of several types.

迄今为止的科学证据以及免疫疗法的历史表明，免疫疗法无疑对患者有危险，而且作为一种癌症治疗方法并无已证实的价值。了解有患者正在接受免疫疗法的医生必须清楚，这些人正面临多种危及生命感染的高风险。